C-peptide (C-Peptide) antibody and antigen (Recombinant protein)

Diagnostic C-peptide (C-Peptide) antibodies (anti-C-peptide, anti-C-Peptide) and antigens (recombinant C-peptide (C-Peptide) protein) for Diabetes diseases C-Peptide detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-C-Peptide-Ag01 Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein 3090
GMP-h-C-Peptide-Ab01 Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) 1953
GMP-h-C-Peptide-Ab02 Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) 1953
GMP-h-C-Peptide-Ab03 Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) 1953
GMP-h-C-Peptide-Ab04 Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-C-Peptide-Ag01
Product Name Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein
Target/Biomarker C-peptide(C-Peptide)
Alias of Target/Biomarker A2HS, AHS, APMR1, FETUA, HSGA
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation C-peptide (C-Peptide) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation.
Products description Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-C-Peptide-Ab01, GMP-h-C-Peptide-Ab02
Product Name Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb)
Target/Biomarker C-peptide(C-Peptide)
Alias of Target/Biomarker A2HS, AHS, APMR1, FETUA, HSGA
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human C-peptide (C-Peptide) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-peptide (C-Peptide) antibodies in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation.
Tag mFc
Products description Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-C-Peptide-Ab03, GMP-h-C-Peptide-Ab04
Product Name Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb)
Target/Biomarker C-peptide(C-Peptide)
Alias of Target/Biomarker A2HS, AHS, APMR1, FETUA, HSGA
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Human C-peptide (C-Peptide) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-peptide (C-Peptide) antibodies in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation.
Tag hFc
Products description Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    C-peptide is a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more constant rate over a longer time. Methods of estimation include urinary and unstimulated and stimulated serum sampling. Modern assays detect levels of c-peptide which can be used to guide diabetes diagnosis and management. C-peptide is a useful and widely used method of assessing pancreatic beta cell function [1, 2]. After cleavage of proinsulin, insulin and the 31-amino-acid peptide c-peptide are produced in equal amounts [3, 4]. So why is c-peptide testing preferable to insulin as a guide to beta cell function? The degradation rate of c-peptide in the body is slower than that of insulin (half-life of 20



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment